ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,942.47
      1.26%
      US Tech 100
      20,762.73
      1.73%
      Dow Jones
      42,732.13
      0.80%
      Brent Oil
      76.495
      0.00%
      Bitcoin
      98,275.06
      0.07%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Crcam Atl ven C (CRAV) Quote

      Crcam Atl ven C

      Crcam Atl ven C (CRAV)

      EU
      87.88
      0.38
      (0.43%)
      Closed January 05 11:30AM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      87.88
      Bid
      80.50
      Ask
      87.88
      Volume
      277
      86.21 Day's Range 87.88
      72.60 52 Week Range 97.35
      Market Cap
      108.854M
      Previous Close
      87.50
      Open
      86.80
      Last Trade
      2
      @
      87.88
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      741
      Shares Outstanding
      1,238,670
      Dividend Yield
      4.22%
      PE Ratio
      0.00
      Earnings Per Share (EPS)
      -
      Revenue
      432.88M
      Net Profit
      86.41M

      About Crcam Atl ven C

      Sector
      Commercial Banks, Nec
      Industry
      Commercial Banks, Nec
      Website
      www.ca-atlantique-vendee.fr
      Headquarters
      Nantes, Loire-atlantique, Fra
      Founded
      -
      Crcam Atl ven C is listed in the Commercial Banks sector of the Euronext with ticker CRAV. The last closing price for Crcam Atl ven C was 87.50 €. Over the last year, Crcam Atl ven C shares have traded in a share price range of 72.60 € to 97.35 €.

      Crcam Atl ven C currently has 1,238,670 shares outstanding. The market capitalization of Crcam Atl ven C is 108.38 € million.

      Ask ADVFN Intelligence (AI)

      CRAV Latest News

      More News
      No news to show yet.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      12.072.4123062580185.818885.8144087.72286201DE
      47.339.0999379267580.558880.5553085.35565058DE
      1211.8815.6315789474768875.874183.78123282DE
      265.576.7670999878582.318874.9845482.42792271DE
      521.331.5366839976986.5597.3572.645183.96973377DE
      156-0.74-0.83502595350988.6299.564.1639883.59467398DE
      260-70.12-44.379746835415818264.1640096.83388651DE

      CRAV - Frequently Asked Questions (FAQ)

      What is the current Crcam Atl ven C share price?
      The current share price of Crcam Atl ven C is 87.88 €
      How many Crcam Atl ven C shares are in issue?
      Crcam Atl ven C has 1,238,670 shares in issue
      What is the market cap of Crcam Atl ven C?
      The market capitalisation of Crcam Atl ven C is EUR 108.38M
      What is the 1 year trading range for Crcam Atl ven C share price?
      Crcam Atl ven C has traded in the range of 72.60 € to 97.35 € during the past year
      What is the reporting currency for Crcam Atl ven C?
      Crcam Atl ven C reports financial results in EUR
      What is the latest annual turnover for Crcam Atl ven C?
      The latest annual turnover of Crcam Atl ven C is EUR 432.88M
      What is the latest annual profit for Crcam Atl ven C?
      The latest annual profit of Crcam Atl ven C is EUR 86.41M
      What is the registered address of Crcam Atl ven C?
      The registered address for Crcam Atl ven C is LA GARDE, ROUTE DE PARIS, NANTES, LOIRE-ATLANTIQUE, 44949
      What is the Crcam Atl ven C website address?
      The website address for Crcam Atl ven C is www.ca-atlantique-vendee.fr
      Which industry sector does Crcam Atl ven C operate in?
      Crcam Atl ven C operates in the COMMERCIAL BANKS, NEC sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MLFXOFinaxo
      0.895 €
      (43.20%)
      		500
      MLWEYWeya
      0.0175 €
      (34.62%)
      		5.1k
      POXELPoxel
      0.191 €
      (33.57%)
      		4.22M
      ALBIOBiosynex
      2.50 €
      (28.73%)
      		50.71k
      SEQUASequana medical NV
      3.02 €
      (23.27%)
      		1.05M
      BNBSTonner Drones
      0.0005 €
      (-50.00%)
      		524.03k
      ALAGOEPango SA
      0.127 €
      (-41.20%)
      		11.94M
      EIFDSTour Eiffel DS
      0.0032 €
      (-38.46%)
      		33.94k
      FINMFinanciere Marjos
      0.076 €
      (-36.13%)
      		1.4k
      ALALOAcheterLouerFR
      0.20 €
      (-33.33%)
      		90.63k
      ATOAtos SE
      0.0024 €
      (-4.00%)
      		1.53B
      BCPBanco Comercial Portugues SA
      0.4623 €
      (0.74%)
      		43.69M
      ALTDTonner Drones
      0.0118 €
      (-7.81%)
      		27.49M
      NEOENNeoen SA
      39.74 €
      (-0.15%)
      		21.76M
      ALVERVergnet
      0.002 €
      (0.00%)
      		16.8M

      Discussion

      View Full Feed
      axelvento axelvento 10 minutes ago
      Q1 the first interim analysis of the vaccine’s efficacy is expected

      Moderna’s mRNA-1647
      Cytomegalovirus
      MRNA
      MightyX MightyX 13 minutes ago
      Yet no one is innocent
      TPTW
      BIG D 4 BIG D 4 13 minutes ago
      WOW !! HAPPY NEW YEAR TO ALL THE LONGS HERE !! I HAVE 2 NAYSAYERS ON IGNORE SO I NEVER READ THEIR BS !! GO SAVING GRACE-- JJ AND ALL THE NEW POSTERS WHO ARE POSITIVE !! .02 CENTS TO START THE RUN TO ONE DOLLAR IS WHERE WE SHOULD BE !! THIS STOCK IS SUCH A GREAT BUY HERE !! I AM LOADED WITH 32 MILLI
      MJNA
      MightyX MightyX 14 minutes ago
      The judicial system legitimizes prosecution
      TPTW
      jondoeuk jondoeuk 15 minutes ago
      A new paper. From it: 'BNT221 was well tolerated across both DLs, with no dose-limiting toxicities of grade 3 or higher attributed to the T cell product observed. Specifically, no cytokine release, immune effector cell-associated neurotoxicity or macrophage activation syndromes were reported. A dose
      BNTX
      benz280c benz280c 16 minutes ago
      Nice to see you are bullish. This quote may round out your knowledge.
      "It is worthy to note that a new CUSIP has been approved by the CUSIP Global Services (CGS).
      Subsequently, we have submitted a corporation action with FINRA for a Company name change, Ticker Symbol Change and Cusip
      GDVM
      shajandr shajandr 17 minutes ago
      Sorry to read that you're still feeling sick. I posted a week or two ago about 41 bunnies and also some cats and dogs that were rescued from a home in Delaware county, Iowa and that were transferred to the DBQ county animal shelter. I just spoke with DaSqu_w and she went to the animal shelter to see
      Lakota-45 Lakota-45 18 minutes ago
      Will do, but I doubt they will listen !!!

      ~ Lol !!!
      IONI
      boi568 boi568 19 minutes ago
      Probably
      AVXL
      HokieHead HokieHead 21 minutes ago
      Wrong..
      TWOH
      HokieHead HokieHead 21 minutes ago
      Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
      TWOH
      Lakota-45 Lakota-45 23 minutes ago
      I agree with you 'farmI1234 !!!

      I'm pretty sure most of the Savvy Investors, that have been paying attention,
      have been loading the dips, and .0004's, for a while now.
      I know I have, along with fishing down stream.

      I doubt any Longs will get caught short,
      WDLF
      CaptHowdy CaptHowdy 24 minutes ago
      RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
      GRLT
      axelvento axelvento 25 minutes ago
      Cancer vaccines: What’s ahead in 2025

      The spotlight is on mRNA-4157 (V940)

      https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
      MRNA
      facts_matter14 facts_matter14 26 minutes ago
      Does this sound like a company with 16 products and a 17th on the way?

      https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








      .
      SRMX
      HomerRomer HomerRomer 26 minutes ago
      More testimony videos from trial participants like the Australian news reel of Ern Heaven would be amazing. I would think that most of the people involved 9 years ago in the earlier phase studies have passed on since the average life expectancy is normally between 3-11 years after being diagnosed w
      AVXL
      CaptHowdy CaptHowdy 27 minutes ago
      That's how to make money on the OTC. 🤦🏻‍♂️ Anyone could do it; only if the effort spent discounting the new leadership in place along with the turn around story underway was used to turn a profit vs. using 9yr old DD to bad mouth new CEO.
      GRLT
      crescentmotor crescentmotor 28 minutes ago
      I think that is a bad precedent to start.

      100% on parading a handful of Blarcamesine patients at the JPM conference. I highly doubt AVXL would involve itself with anecdotal gimmicks where there is no way possible to extrapolate isolated successes to meaningful conclusions about broad
      AVXL JPM
      Steady_T Steady_T 30 minutes ago
      MABS are the current standard of care, so Blarcamesine has to be better than the MABS, which is not saying much.

      I suspect that if Blarcamesine was the equal of the MABS is would still be approved on safety and cost grounds.

      As has been pointed out multiple times on the
      AVXL
      facts_matter14 facts_matter14 31 minutes ago
      Looks like Baggy is worried about Maxine not showing up at CES this week…………….









      .
      SRMX
      Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 32 minutes ago
      Anavex has delayed PD in order to wait out the development of a reliable biomarker, which has happened only during the past few months.

      OK so we should see the test start this quarter then?
      AVXL
      Canna_Business Canna_Business 32 minutes ago
      $FKINX $IONQ $FFALX $MRMD $RKLB $XOM $DUK $LNVGY $V $SOFI $BICEY $VOO $TEMWX
      BICEY DUK FFALX
      mrfence mrfence 32 minutes ago
      Actually, these issues traded on the NYSE under conservatorship and the FHFA made a decision to voluntarily delist Fannie and Freddie from the NYSE. There's Companies in bankruptcy like Gamestop, GME, trading on Big Boards. Unfortunately, the ball's in Gooberment's as to when they see fit to up lis
      GME
      Canna_Business Canna_Business 32 minutes ago
      $FKINX $IONQ $FFALX $MRMD $RKLB $XOM $DUK $LNVGY $V $SOFI $BICEY $VOO $TEMWX
      BICEY DUK FFALX

      Your Recent History

      EU
      CRAV
      Crcam Atl ven C
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads